|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|
||||
| MONDAY, SEPTEMBER 26, 2011 | ||||
| 6:00 PM | Chairman's Reception (By Invitation
Only) Metro Atlanta Chamber |
|||
| TUESDAY, SEPTEMBER 27, 2011 | ||||
7:30 AM |
Career Panel Badge Pickup & Exhibit Hall Set
Up |
|||
| 8:00 AM | BioCareer Resource Center Career Panel - Human Resource Network Seasoned recruiters and career experts will share insights on the current job market, high-demand skills and experience, and tips on transitioning your career to fill high-demand needs. |
|||
| Margot D. King; Founder and Vice President, ZeroChaos, Georgia (Moderator) | ||||
| Lewis Franklin Bost, MBA, IDSA; Professor of the Practice, Wallace H. Coulter Dept. of Biomedical Engineering, Georgia Institute of Technology and Emory University, Georgia | ||||
| Sheryl L. Dollarhide; Executive Director, Global Human Resources Information Systems and US Human Resources, Merial, Ltd., Georgia | ||||
| Mark McCann; Manager, Human Resources, CIBA Vision Johns Creek Manufacturing, Georgia | ||||
| Lynn Sullivan; Account Manager, Aerotek Scientific, Georgia | ||||
| 8:40 AM - 4:00 PM | BioCareer Resource Center / Appointments Available | |||
| 9:00 AM | Official Summit Start: Opening
Remarks Edward J. Schutter, RPh, MBA; 2011 Summit Chair, President and Chief Executive Officer, Arbor Pharmaceuticals, Inc., Georgia |
|
| Video Address: Governor Nathan Deal |
||
| 9:30 AM | Keynote Address: Thomas R. Frieden, MD, MPH; Director, Centers for Disease Control and Prevention; Administrator, Agency for Toxic Substances and Disease Registry |
|
| 10:00 AM | Plenary Presentation: Congressman Jack Kingston |
|
| 10:45 AM | Exhibit Hall Opens / Scientific Poster Viewing (All Day) | |
| 11:45 AM | Official Welcome / Lunch
Plenary Panel: Changing Landscape of Biotech and Pharma |
|
| Thomas A. Davis, MBA; Chief Executive Officer, Coventry Health Care of Georgia, Inc.; Senior Vice President, Coventry Health Care, Inc., Georgia | ||
| Greg Duncan, MBA; Executive Vice President, President of North American Operations, UCB, Inc., Georgia | ||
| Michael Kleinrock; Director, Research Development, IMS Institute for Healthcare Informatics, Pennsylvania | ||
| John "JJ" Spegele; Vice President and General Manager, North and South America, Quintiles Global Central Laboratories, Georgia | ||
| David L. Urdal, PhD; Chief Scientific Officer and Director, Dendreon Corporation, Washington | ||
| Scott Whitaker; Chief Operating Officer, Biotechnology Industry Organization, Washington DC | ||
| 12:45 PM | Break
|
|
| 1:00 PM | CONCURRENT SESSIONS (Tracks
A-Therapeutics, B-Devices, C-Changing Landscape of Pharma,
D-Exciting Science in GA) Track A Session: Emerging Opportunities in Immunotherapy |
|
| Edwin W. Ades, PhD; Pathogenesis Team Lead, Immunology Section, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Georgia (Moderator) | ||
| Charles J. Link, Jr., MD; Founder, Chairman and Chief Scientific Officer, NewLink Genetics Corporation, Iowa | ||
|
Andrew L. Mellor,
PhD; Bradley-Turner and Georgia Research Alliance Eminent Scholar in Molecular Immunogenetics, Professor of Medicine and Director, Immunotherapy Center (CN4151), Co-chair Immunotherapy Discovery Institute, Georgia Health Sciences University, Georgia |
||
| David L. Urdal, PhD; Chief Scientific Officer and Director, Dendreon Corporation, Washington | ||
Track B Session: Medical Device Development Resource Network in Georgia |
||
| Lewis Franklin Bost, MBA, IDSA; Professor of the Practice, Wallace H. Coulter Dept. of Biomedical Engineering, Georgia Institute of Technology and Emory University, Georgia (Moderator) | ||
| Barbara D. Boyan, PhD; Professor and Price Gilbert, Jr. Chair in Tissue Engineering, Associate Dean for Research, College of Engineering, Georgia Research Alliance Eminent Scholar, Wallace H. Coulter Dept. of Biomedical Engineering, Georgia Institute of Technology and Emory University, Georgia | ||
| Nicolas A. Chronos, MD, FACC, FESC, FAHA, FRCP; President and Chief Executive Officer, Saint Joseph's Translational Research Institute, Georgia | ||
| Rick Hillstead, PhD, FAHA; Managing Partner, Peach Seed Capital, Georgia | ||
| Mark A. Samuels; Chief Executive Officer, Lumamed and Commercialization Consultant, Global Center for Medical Innovation (GCMI), Georgia | ||
| Harold H. Shlevin, PhD; Principal, VentureLab and Manager of ATDC-Biosciences, The Georgia Institute of Technology, Georgia | ||
| Stacy Williams Shuker, PhD; Director, Center of Innovation for Life Sciences, Georgia | ||
Track C Session: The Changing Landscape of Big Pharma Partnering: What Are Pharmaceutical and Biotechnology Companies Looking For and How Are They Structuring Their Ventures? |
||
| Edward J. Schutter, RPh, MBA; President and Chief Executive Officer, Arbor Pharmaceuticals, Inc., Georgia (Moderator) | ||
| Charles E. Coleman, MBA; Founding and Principal Partner, Knowledge Acquisition Group, Georgia | ||
| Greg Pahel, PhD; Principal, Innovalyst, LLC, North Carolina | ||
| Brad H. Vale, PhD, DVM; Vice President, Head of Venture Investments, Johnson & Johnson Development Corporation, California | ||
Track D Session: Meeting the Challenges of University Start-Up Companies |
||
| H. Lee Herron, DVM; Vice President of Commercialization, Georgia Research Alliance, Georgia (Moderator) | ||
| David A. Dodd; Chief Executive Officer and Co-Founder, VaxyGen Holdings, LLC, Georgia | ||
| William D. Johnston, PhD; Chief Executive Officer, InVasc Therapeutics, Inc., Georgia | ||
| Thomas J. O'Brien, MBA; President and Chief Executive Officer, Axion BioSystems, Inc, Georgia | ||
| Todd Sherer, PhD, CLP; President-Elect, Association of University Technology Managers (AUTM); Associate Vice President for Research and Director, Office of Technology Transfer, Emory University, Georgia | ||
| 2:00 PM | Break |
|
| 2:15 PM | CONCURRENT SESSIONS (Tracks
A-Therapeutics, B-Devices, C-Changing Landscape of Pharma,
D-Exciting Science in GA) |
|
| Track A Session: Pediatric Nanomedicine: Developing
Nano-scale Tools for Diagnosing and Treating Childhood
Diseases |
||
| Gang Bao, PhD; Robert A. Milton Chair of Biomedical Engineering, Department of Biomedical Engineering, Georgia Institute of Technology and Emory University; Director, Center for Pediatric Nanomedicine, Children's Healthcare of Atlanta, Georgia (Moderator) | ||
|
Paul W. Spearman, MD; Nahmias-Schinazi Professor and Chief, Pediatric Infectious Diseases, Vice Chair for Research, Emory Department of Pediatrics, Emory University and Chief Research Officer, Children's Healthcare of Atlanta, Georgia |
||
| Michael Weinrich, MD; Director, National Center for Rehabilitation Research, National Institute of Child Health and Human Development, National Institutes of Health, Maryland | ||
| Paula Cannon, PhD; Associate Professor, Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, California | ||
Track B Session: Concept to Commercialization: Exploring the Challenges of Bringing Innovation to Market |
||
| Doreen L. Linneman, MBA; Founder and President, The Riverbend Group, LLC, Georgia (Moderator) | ||
| Rebeccah J.C. Brown, PhD; Executive Vice President, Product Development, MiMedx Group, Inc., Georgia | ||
| Mark Gilreath, MBA; Founder, President and Chief Executive Officer, EndoChoice Inc., Georgia | ||
| Ken Green, PhD; Senior Vice President and Chief Scientific Officer, Alimera Sciences, Georgia | ||
| David H. Mason, Jr., MD; Senior Vice President and Chief Medical Officer, Given Imaging, Inc., Georgia | ||
Track C Session: New Challenges for a New Age: Perspectives from Industry Experts |
||
| John Durkee, RPh, MBA; Vice President, Business Development & Marketing, Peachtree BioResearch Solutions, Inc., Georgia (Moderator) | ||
| Charles Hrushka, MBA; Senior Consultant, Giles & Associates Consultancy, Illinois | ||
| Mark Perlotto; President and Founder, Excitant Healthcare Advertising, Georgia | ||
| Harold H. Shlevin, PhD; Principal, VentureLab and Manager of ATDC-Biosciences, The Georgia Institute of Technology, Georgia | ||
| Daniel White, MBA; President and Chief Executive Officer, Clearside BioMedical Inc, Georgia | ||
Track D Session: Thirty Years after the Bayh-Dole Act: Successful Innovations in Georgia |
||
| Todd Sherer, PhD, CLP; President-Elect, Association of University Technology Managers (AUTM); Associate Vice President for Research and Director, Office of Technology Transfer, Emory University, Georgia (Moderator) | ||
| Vincent La Terza; Head Corporate Development, NeurOp, Inc., Georgia | ||
| Robert T. McNally, PhD; President and Chief Executive Officer, GeoVax Labs, Inc., Georgia | ||
| Stefan Schulze, MS, MBA; Associate Director, Georgia BioBusiness Center, The University of Georgia, Georgia | ||
| 3:15 PM | Break |
|
| 3:30 PM | CONCURRENT SESSIONS (Tracks
A-Therapeutics, B-Devices, C-Changing Landscape of Pharma,
D-Exciting Science in GA) |
|
| Track A Session: Personalized Medicine - Opportunities and
Challenges |
||
| Amyn M. Rojiani, MD, PhD; Georgia Cancer Coalition Distinguished Cancer Scholar; E.R. Pund Distinguished Professor and Chairman of the Department of Pathology, Georgia Health Sciences University, Georgia (Moderator) | ||
| Personalized Medicine and Its Impact on Cancer Care Farrukh T. Awan, MD; Assistant Professor, Department of Medicine, Hematology-Oncology Section, Georgia Health Sciences University, Georgia |
||
| Biospecimen Resources: Essential Tools for Personalized Medicine Judith G. Giri, PhD; Director, BioRepository Alliance of Georgia for Oncology and Medical College of Georgia Tumor Tissue and Serum Biorepository; Associate Professor, Department of Pathology, Georgia Health Sciences University, Georgia |
||
|
Innovation in Personalized Medicine: Companion Diagnostics Pedro L. Rodriguez, PhD; Principal Applications Scientist, Medical and Scientific Affairs, Roche Diagnostics Corporation, Florida |
||
|
Personalized Medicine within the Community Cancer Center Utilizing a New NCI Resource- the NCCCP Howard A. Zaren, MD, FACS; Medical Director and Surgical Oncologist, Nancy N. and J.C. Lewis Cancer & Research Pavilion; Principal Investigator for the NCI's Community Cancer Centers Program (NCCCP); and Professor of Surgery, Georgia Life Sciences University, Georgia |
||
Track B Session: The Emergence of Wireless Technologies in Health Care |
||
| Ralph M. Herkert, PE; Principal Research Engineer and Center Director, Medical Device Test Center, Georgia Tech Research Institute, Georgia (Moderator) | ||
| Robert Delano; Research Scientist, Georgia Tech Research Institute, Georgia | ||
| Bill Garner; Global Marketing Director, Given Imaging Ltd., Georgia | ||
| Chip Standifer; Vice President Product Development, LifeSync Corporation, Georgia | ||
| Lisa Stepps; Project Manager, Cardiovascular Services, St. Joseph's Hospital of Atlanta, Georgia | ||
Track C Session: Convergence of Pharma, Biotech and Health IT Developed in Partnership with the Healthcare Information and Management Systems Society (HIMSS) |
||
| Mike Mosquito, MBA; President and Chief Executive Officer, HealthNovation, Georgia (Moderator) | ||
| Monty Green; Manager, Emerging Markets Solutions, SAIC, Georgia | ||
| Patricia Mozzicato, MD; MedDRA MSSO, Northrop Grumman Health IT Programs, Virginia | ||
| Ketan Paranjape, MS, MBA; Chief of Staff, Healthcare Innovation and Policy, Intel Corporation, Oregon | ||
Track D Session: Genomics as Part of Integrated Healthcare in Georgia |
||
| Bradford W. Coffee, PhD, FACMG; Director, Emory Molecular Genetics Laboratory, Emory University School of Medicine, Georgia (Moderator) | ||
|
Angela M. Caliendo, MD, PhD; Professor, Pathology and Laboratory Medicine; Director, Division of Clinical Pathology, Emory University School of Medicine, Georgia |
||
| Linda A. Robbie, PhD; Director, Global Assay Development Laboratory, Quintiles, Georgia | ||
| 4:30 PM | Break |
|
| 4:45 PM | Closing Plenary Panel: Neuroscience Innovation and the Role of Georgia's Scientific, Medical and Military Communities |
|
| Ravi V. Bellamkonda, PhD; Georgia Cancer Coalition Distinguished Cancer Scholar; Professor, Associate Vice President of Research, Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Georgia | ||
| Ross Mason, MBA; Founder, Healthcare Institute for Neuro-Recovery and Innovation (HINRI) and HealthTrain Ventures, Georgia | ||
| Valerie Montgomery Rice, MD; Dean and Executive Vice President, Morehouse School of Medicine, Georgia | ||
| Scott Rigsby; Chief Inspiration Officer, The Scott Rigsby Foundation, Georgia | ||
| Colonel David Wilkie, MD; Chief, Neuroscience and Rehabilitation, Dwight D. Eisenhower Army Medical Center, Georgia | ||
| 5:30 PM | Closing Remarks: Edward J. Schutter, RPh, MBA; 2011 Summit Chair, President and Chief Executive Officer, Arbor Pharmaceuticals, Inc., Georgia |
|
| Anthony Shuker Scientific Poster Awards Announcement of Poster Winners: Stacy Williams Shuker, PhD; Director, Center of Innovation for Life Sciences, Georgia |
||
| 5:45 PM | Reception in Exhibit Hall | |
| 7:00 PM | Exhibit Hall Closed / Summit End | |
|
|
||